{"id":3130,"date":"2009-05-16T15:47:18","date_gmt":"2009-05-16T14:47:18","guid":{"rendered":"http:\/\/www.ethicalquote.com\/index.php\/2009\/05\/25\/3-reasons-why-45-of-the-big-pharma-don%e2%80%99t-embrace-social\/"},"modified":"2009-06-05T14:04:51","modified_gmt":"2009-06-05T13:04:51","slug":"3-reasons-why-45-of-the-big-pharma-dont-embrace-social","status":"publish","type":"post","link":"https:\/\/www.covalence.ch\/index.php\/2009\/05\/16\/3-reasons-why-45-of-the-big-pharma-dont-embrace-social\/","title":{"rendered":"3 Reasons Why 45 of the Big Pharma Don\u2019t Embrace Social"},"content":{"rendered":"<p><a href=\"http:\/\/www.kevinfrench.com\/2009\/05\/3-reasons-why-45-of-the-big-pharma-dont-embrace-social\/\" title=\"090526_pfizer.jpg\"><img decoding=\"async\" src=\"http:\/\/www.ethicalquote.com\/newTemplate\/wp-content\/uploads\/2009\/05\/090526_pfizer.jpg\" title=\"090526_pfizer.jpg\" alt=\"090526_pfizer.jpg\" align=\"right\" \/><\/a>At the risk of stating the obvious, consumer expectations will continue to change and marketers\u2019 level of embrace will continue to amplify towards the the rapidly changing and increasingly powerful social platform. With the understanding that pharma is an extremely heavily regulated industry, you still have to wonder why more pharmaceutical marketers not only don\u2019t embrace social, but many cringe at the mere thought of a social task. Image source: kevinfrench.com. &gt; <a href=\"http:\/\/www.kevinfrench.com\/2009\/05\/3-reasons-why-45-of-the-big-pharma-dont-embrace-social\/\">Continue<\/a>.<\/p>\n<p>News selected by Covalence <span class=\"LinkBlueTransMedium\">| Country: <\/span>Global<span class=\"LinkBlueTransMedium\"><\/span><span lang=\"EN-GB\"> | <\/span><span lang=\"EN-GB\">Company &#8211; EthicalQuote link<\/span><span lang=\"EN-GB\">: <a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=7\" target=\"_blank\">Pfizer<\/a><\/span><span style=\"font-size: 9pt; font-family: Arial\" lang=\"EN-GB\"><a href=\"http:\/\/www.ethicalquote.com\/newTemplate\/index.php\/ethicalquote\/?value=7\" target=\"_blank\">, Merck , Novartis, Roche<\/a> | <\/span><span class=\"LinkBlueTransMedium\"> <\/span>Source: <a href=\"http:\/\/www.kevinfrench.com\/2009\/05\/3-reasons-why-45-of-the-big-pharma-dont-embrace-social\/\">Kevin<\/a><a href=\"http:\/\/www.kevinfrench.com\/2009\/05\/3-reasons-why-45-of-the-big-pharma-dont-embrace-social\/\"> French<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>At the risk of stating the obvious, consumer expectations will continue to change and marketers\u2019 level of embrace will continue to amplify towards the the rapidly changing and increasingly powerful social platform. With the understanding that pharma is an extremely heavily regulated industry, you still have to wonder why more pharmaceutical marketers not only don\u2019t&hellip;<\/p>\n","protected":false},"author":665,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"wds_primary_category":0,"wds_primary_post_series":0,"footnotes":""},"categories":[1],"tags":[42],"post_series":[],"class_list":["post-3130","post","type-post","status-publish","format-standard","hentry","category-news","tag-pfizer","entry","no-media"],"_links":{"self":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/3130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/users\/665"}],"replies":[{"embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/comments?post=3130"}],"version-history":[{"count":0,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/posts\/3130\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/media?parent=3130"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/categories?post=3130"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/tags?post=3130"},{"taxonomy":"post_series","embeddable":true,"href":"https:\/\/www.covalence.ch\/index.php\/wp-json\/wp\/v2\/post_series?post=3130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}